Why it was recalled
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.
Product description
Westminister Irbesartan Tablets, USP, 300mg, Rx Only,(a) 30-count bottle (NDC 69367-121-01, (b) 90-count bottle (NDC 69367-121-03), Manufactured by ScieGen Pharmaceuticals Inc. Hauppauge, NY 11755. Manufactured for Westminster Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA.
Lot numbers, UPCs & expiration codes
69367-121-01 Irbesartan 300mg Tablets, 30 count bottle B162008A Sep-19 C162002A Feb-20 69367-121-03 Irbesartan 300mg Tablets, 90 count bottle B162008B Sep-19 C162002B Feb-20
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0269-2019
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Oct 29, 2018
- FDA report date
- Nov 28, 2018
- Quantity
- 5,989 HDPE
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Sciegen Pharmaceuticals Inc
Original FDA data
Every field from FDA enforcement report D-0269-2019, exactly as published.
Show all FDA fields
- City
- Hauppauge
- State
- NY
- Status
- Terminated
- Country
- United States
- Event ID
- 81458
- Address
- 89 Arkay Dr
- Code information
- 69367-121-01 Irbesartan 300mg Tablets, 30 count bottle B162008A Sep-19 C162002A Feb-20 69367-121-03 Irbesartan 300mg Tablets, 90 count bottle B162008B Sep-19 C162002B Feb-20
- Postal code
- 11788-3727
- Report date
- Nov 28, 2018
- Product type
- Drugs
- Recall number
- D-0269-2019
- Classification
- Class II
- Recalling firm
- Sciegen Pharmaceuticals Inc
- Product quantity
- 5,989 HDPE
- Termination date
- Sep 25, 2023
- Reason for recall
- CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Westminister Irbesartan Tablets, USP, 300mg, Rx Only,(a) 30-count bottle (NDC 69367-121-01, (b) 90-count bottle (NDC 69367-121-03), Manufactured by ScieGen Pharmaceuticals Inc. Hauppauge, NY 11755. Manufactured for Westminster Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA.
- Distribution pattern
- Nationwide
- Recall initiation date
- Oct 29, 2018
- Initial firm notification
- Press Release
- Center classification date
- Nov 20, 2018